PortfoliosLab logoPortfoliosLab logo
APGE vs. RVMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

APGE vs. RVMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Apogee Therapeutics Inc. Common Stock (APGE) and Revolution Medicines, Inc. (RVMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, APGE achieves a 77.65% return, which is significantly lower than RVMD's 135.44% return.


APGE

1D
-0.16%
1M
0.89%
6M
104.69%
YTD
77.65%
1Y
255.21%
3Y*
84.27%
5Y*
10Y*
ALL TIME*
82.34%

RVMD

1D
-2.41%
1M
-0.90%
6M
93.43%
YTD
135.44%
1Y
411.96%
3Y*
81.24%
5Y*
45.62%
10Y*
ALL TIME*
34.07%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$128.05M$169.87M$317.81M
$346.97M$364.41M$450.00M

APGE vs. RVMD - Yearly Performance Comparison


2026 (YTD)202520242023
APGE
Apogee Therapeutics Inc. Common Stock
77.65%66.62%62.13%29.95%
RVMD
Revolution Medicines, Inc.
135.44%82.10%52.51%8.10%

Correlation

The correlation between APGE and RVMD is 0.44, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.44

Correlation (3Y)
Balances recent behavior with more history.

0.41

Correlation (All Time)
Calculated using the full available price history since Jul 14, 2023

0.41

Fundamentals

Market Cap

APGE:

$8.30B

RVMD:

$39.87B

EPS

APGE:

-$3.18

RVMD:

-$7.13

PB Ratio

APGE:

7.44

RVMD:

24.77

Total Revenue (TTM)

APGE:

$0.00

RVMD:

$0.00

Gross Profit (TTM)

APGE:

$0.00

RVMD:

-$4.70M

EBITDA (TTM)

APGE:

-$297.75M

RVMD:

-$1.34B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

APGE vs. RVMD — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

APGE
APGE Risk / Return Rank: 9999
Overall Rank
APGE Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
APGE Sortino Ratio Rank: 9999
Sortino Ratio Rank
APGE Omega Ratio Rank: 9898
Omega Ratio Rank
APGE Calmar Ratio Rank: 9999
Calmar Ratio Rank
APGE Martin Ratio Rank: 9999
Martin Ratio Rank

RVMD
RVMD Risk / Return Rank: 9999
Overall Rank
RVMD Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
RVMD Sortino Ratio Rank: 9999
Sortino Ratio Rank
RVMD Omega Ratio Rank: 9999
Omega Ratio Rank
RVMD Calmar Ratio Rank: 9999
Calmar Ratio Rank
RVMD Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

APGE vs. RVMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Apogee Therapeutics Inc. Common Stock (APGE) and Revolution Medicines, Inc. (RVMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


APGERVMDDifference
Sharpe ratioReturn per unit of total volatility

-2.45

Sortino ratioReturn per unit of downside risk

-1.30

Omega ratioGain probability vs. loss probability

1.67

1.93

-0.25

Calmar ratioReturn relative to maximum drawdown

10.24

16.29

-6.05

Martin ratioReturn relative to average drawdown

31.57

40.39

-8.81

APGE vs. RVMD - Sharpe Ratio Comparison

The current APGE Sharpe Ratio is 3.57, which is lower than the RVMD Sharpe Ratio of 6.01. The chart below compares the historical Sharpe Ratios of APGE and RVMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

APGE vs. RVMD - Drawdown Comparison

The maximum APGE drawdown since its inception was -58.75%, smaller than the maximum RVMD drawdown of -73.29%. Use the drawdown chart below to compare losses from any high point for APGE and RVMD.


Loading charts...

Drawdown Indicators


APGERVMDDifference

Max Drawdown

Largest peak-to-trough decline

-58.75%

-73.29%

+14.54%

Max Drawdown (1Y)

Largest decline over 1 year

-24.63%

-24.95%

+0.32%

Max Drawdown (3Y)

Largest decline over 3 years

-58.75%

-48.63%

-10.12%

Max Drawdown (5Y)

Largest decline over 5 years

-56.85%

Current Drawdown

Current decline from peak

-0.16%

-2.64%

+2.48%

Average Drawdown

Average peak-to-trough decline

-23.26%

-35.01%

+11.75%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.97%

10.04%

-2.07%

Volatility

APGE vs. RVMD - Volatility Comparison

The current volatility for Apogee Therapeutics Inc. Common Stock (APGE) is 0.70%, while Revolution Medicines, Inc. (RVMD) has a volatility of 10.50%. This indicates that APGE experiences smaller price fluctuations and is considered to be less risky than RVMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


APGERVMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.70%

10.50%

-9.80%

Volatility (6M)

Calculated over the trailing 6-month period

52.57%

45.53%

+7.04%

Volatility (1Y)

Calculated over the trailing 1-year period

70.76%

67.61%

+3.15%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

71.00%

62.48%

+8.52%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

71.00%

65.34%

+5.66%

Dividends

APGE vs. RVMD - Dividend Comparison

Neither APGE nor RVMD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

APGE vs. RVMD - Financials Comparison

This section allows you to compare key financial metrics between Apogee Therapeutics Inc. Common Stock and Revolution Medicines, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


APGE and RVMD have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RVMD has higher volatility (10.50%) compared to APGE (0.70%). In terms of maximum drawdown, APGE dropped -58.75% vs RVMD's -73.29%.

RVMD currently has the higher Sharpe Ratio (6.01 vs 3.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for APGE and RVMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer